New York Business Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Business Digest.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 6, 2025

Dec. 6, 2025

SEO Image Positioned as an Authority in Generative Engine Optimization, Online Reputation Management & SEO Services

EIN Presswire

Dec. 6, 2025

ARH Global Advisors Releases 2026 Manhattan Probate & Trust Real Estate Market Outlook

EIN Presswire

Dec. 6, 2025

Dr. Kevin Miller Selected as Top Global Communications and Healthcare Executive of the Decade by IAOTP

EIN Presswire

Dec. 6, 2025

ThinkCareBelieve: Week 46 America Shining Brightly

GlobeNewswire

Dec. 6, 2025

CRMT Investor News: If You Have Suffered Losses in America’s Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire

Dec. 6, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

Dec. 6, 2025

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire

Dec. 6, 2025

DXCM DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire

Dec. 6, 2025

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Sprouts Farmers Market, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SFM

GlobeNewswire

Dec. 6, 2025

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKYE

GlobeNewswire

Dec. 6, 2025

ROSEN, A RANKED AND LEADING FIRM, Encourages Perrigo Company plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – PRGO

GlobeNewswire

Dec. 6, 2025

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - JYD

GlobeNewswire

Dec. 6, 2025

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP

GlobeNewswire

Dec. 6, 2025

BioNTechs und OncoC4s selektiver Treg-Modulatorkandidat Gotistobart erzielte klinisch relevanten Gesamtüberlebensvorteil bei Patientinnen und Patienten mit zuvor behandeltem Plattenepithelkarzinom der Lunge

GlobeNewswire

Dec. 6, 2025

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

GlobeNewswire

Dec. 6, 2025

Geekstake Reviews Risk Signals Across Multi-Chain Networks in Response to Global Economic Uncertainty

GlobeNewswire

Dec. 6, 2025

ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire

Dec. 6, 2025

Former National Security Analyst Warns in Recent Presentation: “America Can’t Sit Around Twiddling Their Thumbs”

GlobeNewswire

Dec. 6, 2025

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting

GlobeNewswire

Dec. 6, 2025

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

GlobeNewswire